Thu, March 28, 2024
Wed, March 27, 2024
Tue, March 26, 2024

Andrew Fein Maintained (ABOS) at Strong Buy and Held Target at $15 on, Mar 27th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-15-on-mar-27th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Andrew Fein of HC Wainwright & Co., Maintained "Acumen Pharmaceuticals, Inc." (ABOS) at Strong Buy and Held Target at $15 on, Mar 27th, 2024.

Andrew has made no other calls on ABOS in the last 4 months.



There is 1 other peer that has a rating on ABOS. Out of the 1 peers that are also analyzing ABOS, 0 agree with Andrew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Andrew


  • Neena Bitritto-Garg of "Deutsche Bank" Initiated at Strong Buy and Held Target at $8 on, Tuesday, December 12th, 2023

Publication Contributing Sources